115 related articles for article (PubMed ID: 6800794)
1. Tamoxifen in the therapy of post-menopausal endometrial cancer: variations in some hormonal parameters.
Marchesoni D; Mozzanega B; Gangemi M; Enrichi M
Eur J Gynaecol Oncol; 1980 May; 1(2):116-21. PubMed ID: 6800794
[No Abstract] [Full Text] [Related]
2. Hormonal and receptor status in postmenopausal women with endometrial carcinoma before and after treatment with tamoxifen.
Luciani L; Oriana S; Spatti G; Secreto G; Recchione C; Grignoglio E; Andreola S; Coradini D; Ronchi E; Di Fronzo G
Tumori; 1984 Apr; 70(2):189-92. PubMed ID: 6428017
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma.
Bonte J; Ide P; Billiet G; Wynants P
Gynecol Oncol; 1981 Apr; 11(2):140-61. PubMed ID: 6783481
[No Abstract] [Full Text] [Related]
4. Profiles and endocrine correlations in endometrial carcinoma.
Falsetti L; Omodei U; Dordoni D; Scagliola P; Turla R; Zotti L; Archetti L
Eur J Gynaecol Oncol; 1983; 4(1):30-4. PubMed ID: 6407836
[TBL] [Abstract][Full Text] [Related]
5. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
Spona J; Ulm R; Bieglmayer C; Husslein P
Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
[TBL] [Abstract][Full Text] [Related]
6. Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.
Nakamura Y; Yoshimura Y
Clin Obstet Gynecol; 1993 Sep; 36(3):660-7. PubMed ID: 8403612
[No Abstract] [Full Text] [Related]
7. Plasma hormones in patients with advanced breast cancer treated with tamoxifen.
Golder MP; Phillips ME; Fahmy DR; Preece PE; Jones V; Henk JM; Griffiths K
Eur J Cancer (1965); 1976 Sep; 12(9):719-23. PubMed ID: 971694
[No Abstract] [Full Text] [Related]
8. Sex hormones in postmenopausal women with breast cancer on tamoxifen.
Kostoglou-Athanassiou I; Ntalles K; Gogas J; Markopoulos C; Alevizou-Terzaki V; Athanassiou P; Georgiou E; Proukakis C
Horm Res; 1997; 47(3):116-20. PubMed ID: 9050950
[TBL] [Abstract][Full Text] [Related]
9. Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer.
Vishnevsky AS; Shtofmakher JA; Bokhman JV; Tsyrlina EV; Bobrov JF; Chepick OF; Sofroniy DF
Clin Exp Obstet Gynecol; 1990; 17(3-4):159-62. PubMed ID: 2127240
[TBL] [Abstract][Full Text] [Related]
10. [Hormonal status of patients with uterine cancer during surgical treatment].
Musina RKh; Kiseleva NS; Modnikov OP
Vopr Onkol; 1987; 33(8):99-102. PubMed ID: 2820150
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen and oligospermia.
Noci I; Chelo E; Saltarelli O; Donati Cori G; Scarselli G
Arch Androl; 1985; 15(1):83-8. PubMed ID: 3938205
[TBL] [Abstract][Full Text] [Related]
12. Climacteric symptoms, fat mass, and plasma concentrations of LH, FSH, Prl, oestradiol-17 beta and androstenedione in the early post-menopausal period.
Hagen C; Christiansen C; Christensen MS; Transbøl I
Acta Endocrinol (Copenh); 1982 Sep; 101(1):87-92. PubMed ID: 6812347
[No Abstract] [Full Text] [Related]
13. Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
Blackburn AM; Wang DY; Bulbrook RD; Thomas BS; Kwa HG; Hoare SA; Rubens RD
Cancer Treat Rep; 1984 Dec; 68(12):1447-53. PubMed ID: 6239689
[TBL] [Abstract][Full Text] [Related]
14. GnRH--test in menopause. Its possible use in identifying the subjects at risk for dysplastic endometrial pathology.
Marchesoni D; Gangemi M; Mozzanega B; Meneghetti G; Maggino T
Clin Exp Obstet Gynecol; 1981; 8(3):114-8. PubMed ID: 6804131
[TBL] [Abstract][Full Text] [Related]
15. Hormone levels in healthy post-menopausal women and in women with post-menopausal bleeding with or without endometrial carcinoma.
von Holst T; Klinga K; Runnebaum B
Maturitas; 1981 Dec; 3(3-4):315-20. PubMed ID: 6801439
[No Abstract] [Full Text] [Related]
16. [Hormonal correlations in uterine myoma, internal endometriosis and diffuse mastopathy in patients with a retained biphasic menstrual cycle].
Sokolova ZP
Akush Ginekol (Mosk); 1982 Jun; (6):15-9. PubMed ID: 6812446
[No Abstract] [Full Text] [Related]
17. [The level of steroid hormone receptors in endometrial cancer].
Bieglmayer C; Spona J; Ulm R; Husslein P
Acta Univ Palacki Olomuc Fac Med; 1981; 101():159-65. PubMed ID: 6211045
[No Abstract] [Full Text] [Related]
18. Evidence suggesting the trophoblastic origin of follicle-stimulating hormone, luteinizing hormone and prolactin in hydatidiform mole.
Loganath A; Peh KL; Gunasegaram R; Ratnam SS
Asia Oceania J Obstet Gynaecol; 1988 Sep; 14(3):383-8. PubMed ID: 2460076
[No Abstract] [Full Text] [Related]
19. [Therapeutic results with tamoxifen in oligospermia. II. Hormonal analysis and semen parameters].
Schieferstein G; Adam W; Armann J; Bantel E; Cörlin R; Egenrieder H; Fierlbeck G; Hook B; Schiek A; Schubring G
Andrologia; 1987; 19(3):333-41. PubMed ID: 3115143
[TBL] [Abstract][Full Text] [Related]
20. The role of prolactin in the menopause.
Metka M; Holzer G; Raimann H; Heytmanek G; Hartmann B; Kurz C
Maturitas; 1994 Dec; 20(2-3):151-4. PubMed ID: 7715467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
